MC4R and hyperinsulinemic hypoglycemia, familial, 4: Collet et al., in 2017 [50], demonstrated that setmelanotide, a potent MC4R agonist, can lead to body weight loss in obese people with MC4R deficiency, although the mechanisms of weight loss are still not clear.